Rajiv Pathak

Researcher

University of Arkansas for Medical Sciences

unknown

2 h-index 2 pubs 7 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Rajiv Pathak's research focuses on understanding molecular mechanisms underlying diseases and developing potential therapeutic strategies. His recent work includes an investigation into Interleukin-10 as a biomarker for COVID-19, exploring its analogues through network pharmacology. Additionally, Pathak has studied novel thienopyrimidine-hydrazinyl compounds, demonstrating their ability to induce non-apoptotic cell death in triple-negative breast cancer cells via DRP1. This cancer research specifically targets mechanisms related to cell death pathways.

Pathak collaborates with researchers such as Mary Qu Yang from the University of Arkansas at Little Rock, with whom he shares a publication. His scholarly output to date includes two publications and has garnered seven citations, with an h-index of 2. Pathak remains actively engaged in research, as indicated by his recent publication in 2024.

Metrics

  • h-index: 2
  • Publications: 2
  • Citations: 7

Selected Publications

  • Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells (2024) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics